{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:43:22Z","timestamp":1792593802271,"version":"4.5.0"},"reference-count":43,"publisher":"MyJove Corporation","issue":"224","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69038","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:01:27Z","timestamp":1760742087000},"source":"Crossref","is-referenced-by-count":0,"title":["Cholesterol and Stearamide Mediate Lymphocyte Apoptosis and Cytokine Secretion in Systemic Lupus Erythematosus"],"prefix":"10.3791","author":[{"given":"Xuejia","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingquan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingquan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","type":"journal-article","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","unstructured":"Barber, M. R. et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 17 (8), 515-532 (2021).","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2021.11.005","type":"journal-article","article-title":"Deconvoluting the heterogeneity of SLE: the contribution of ancestry","volume":"149","author":"Owen","year":"2022","unstructured":"Owen, K. A., Grammer, A. C., Lipsky, P. E. Deconvoluting the heterogeneity of SLE: the contribution of ancestry. J Allergy Clin Immunol. 149 (1), 12-23 (2022).","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molmed.2020.09.009","type":"journal-article","article-title":"Leveraging heterogeneity in systemic lupus erythematosus for new therapies","volume":"27","author":"Allen","year":"2021","unstructured":"Allen, M.E., Rus, V., Szeto, G.L. Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med. 27 (2), 152-171 (2021).","journal-title":"Trends Mol Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/annrheumdis-2020-219373","type":"journal-article","article-title":"European League against Rheumatism (EULAR)\/American College of Rheumatology (ACR) SLE classification criteria item performance","volume":"80","author":"Aringer","year":"2021","unstructured":"Aringer, M. et al. European League against Rheumatism (EULAR)\/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 80 (6), 775-781 (2021).","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/metabo11120812","type":"journal-article","article-title":"Metabolomics in autoimmune diseases: Focus on rheumatoid arthritis, systemic lupus erythematous, and multiple sclerosis","volume":"11","author":"Yoon","year":"2021","unstructured":"Yoon, N., Jang, A.K., Seo, Y., Jung, B.H. Metabolomics in autoimmune diseases: Focus on rheumatoid arthritis, systemic lupus erythematous, and multiple sclerosis. Metabolites. 11 (8), 812 (2021).","journal-title":"Metabolites"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"110235","DOI":"10.1016\/j.clim.2024.110235","type":"journal-article","article-title":"Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity","volume":"264","author":"Liang","year":"2024","unstructured":"Liang, J. et al. Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity. Clin Immunol. 264, 110235 (2024).","journal-title":"Clin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1443440","DOI":"10.3389\/fimmu.2024.1443440","type":"journal-article","article-title":"A review on the novel biomarkers of systemic lupus erythematosus discovered via metabolomic profiling","volume":"15","author":"Liu","year":"2024","unstructured":"Liu, Y., Yang, X. A review on the novel biomarkers of systemic lupus erythematosus discovered via metabolomic profiling. Front Immunol. 15, 1443440 (2024).","journal-title":"Front Immunol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12866-025-03995-5","type":"journal-article","article-title":"Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis","volume":"25","author":"Cheng","year":"2025","unstructured":"Cheng, S. et al. Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis. BMC Microbiol. 25 (1), 275 (2025).","journal-title":"BMC Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.36557\/2674-8169.2024v6n9p647-660","type":"journal-article","article-title":"Systemic lupus erythematosus (SLE): Most common clinical manifestations and renal complications","volume":"6","author":"J\u00fanior","year":"2024","unstructured":"J\u00fanior, V. F. A. J. A., Silva, S. M., Amaral, A. L., Perini, J. V. de F. V., dos Santos, J. E. N. Systemic lupus erythematosus (SLE): Most common clinical manifestations and renal complications. Braz J Implantol Health Sci. 6, 647-660 (2024).","journal-title":"Braz J Implantol Health Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"109330","DOI":"10.1016\/j.clim.2023.109330","type":"journal-article","article-title":"Serum proteome and metabolome uncover novel biomarkers for the assessment of disease activity and diagnosing of systemic lupus erythematosus","volume":"251","author":"He","year":"2023","unstructured":"He, J. et al. Serum proteome and metabolome uncover novel biomarkers for the assessment of disease activity and diagnosing of systemic lupus erythematosus. Clin Immunol. 251, 109330 (2023).","journal-title":"Clin Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.3390\/ijms252010905","type":"journal-article","article-title":"Lymphocytes change their phenotype and function in systemic lupus erythematosus and lupus nephritis","volume":"25","author":"Moysidou","year":"2024","unstructured":"Moysidou, E. et al. Lymphocytes change their phenotype and function in systemic lupus erythematosus and lupus nephritis. Int J Mol Sci. 25, 10905 (2024).","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"874562","DOI":"10.3389\/fendo.2022.1000627","type":"journal-article","article-title":"A Mendelian randomization study to assess the genetic liability of type 1 diabetes mellitus for IgA nephropathy","volume":"13","author":"Deng","year":"2022","unstructured":"Deng, P., Li, Z., Yi, B., Leng, Y. A Mendelian randomization study to assess the genetic liability of type 1 diabetes mellitus for IgA nephropathy. Front Endocrinol. 13, 874562 (2022).","journal-title":"Front Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","type":"journal-article","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","unstructured":"Wang, Y.F. et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun. 12, 772 (2021).","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJMoa0707865","type":"journal-article","article-title":"Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX","volume":"358","author":"Hom","year":"2008","unstructured":"Hom, G. et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 358, 900-909 (2008).","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","type":"journal-article","article-title":"An atlas of genetic influences on human blood metabolites","volume":"46","author":"Shin","year":"2014","unstructured":"Shin, S.Y. et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 46, 543-550 (2014).","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","type":"journal-article","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","unstructured":"Kettunen, J. et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 7, 11122 (2016).","journal-title":"Nat Commun"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiae357","type":"journal-article","article-title":"Instrumental variables analysis and mendelian randomization for causal inference","volume":"231","author":"Moodie","year":"2025","unstructured":"Moodie, E. E., le Cessie, S. Instrumental variables analysis and mendelian randomization for causal inference. J Infect Dis. 231 (3), 556-558 (2025).","journal-title":"J Infect Dis"},{"key":"ref18","type":"journal-article","article-title":"Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study","volume":"9","author":"Zhang","year":"2023","unstructured":"Zhang, S., Zhang, W., Sun, H., Xue, R., Lv, Q. Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study. Heliyon. 9, (2023).","journal-title":"Heliyon"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1136\/gutjnl-2024-332280","type":"journal-article","article-title":"Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis","volume":"74","author":"Yuan","year":"2025","unstructured":"Yuan, S., Larsson, S. C., Gill, D., Burgess, S. Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis. Gut. 74, e6-e6 (2025).","journal-title":"Gut"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","type":"journal-article","article-title":"Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model","volume":"17","author":"Lin","year":"2021","unstructured":"Lin, Z., Deng, Y., Pan, W. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet. 17 (1), e1009922 (2021).","journal-title":"PLoS Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12916-022-02246-y","type":"journal-article","article-title":"Systematic review of Mendelian randomization studies on risk of cancer","volume":"20","author":"Markozannes","year":"2022","unstructured":"Markozannes, G. et al. Systematic review of Mendelian randomization studies on risk of cancer. BMC Med. 20, 41 (2022).","journal-title":"BMC Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-023-02881-z","type":"journal-article","article-title":"The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study","volume":"21","author":"Li","year":"2023","unstructured":"Li, Y. et al. The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study. BMC Med. 21, 195 (2023).","journal-title":"BMC Med"},{"issue":"25","key":"ref23","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1002\/sim.9156","type":"journal-article","article-title":"Pleiotropy robust methods for multivariable Mendelian randomization","volume":"40","author":"Grant","year":"2021","unstructured":"Grant, A. J., Burgess, S. Pleiotropy robust methods for multivariable Mendelian randomization. Stat Med. 40 (25), 5813-5830 (2021).","journal-title":"Stat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1268492","DOI":"10.3389\/fmicb.2023.1268492","type":"journal-article","article-title":"No evidence for a causal link between Helicobacter pylori infection and irritable bowel syndrome: a Mendelian randomization study","volume":"14","author":"Wang","year":"2024","unstructured":"Wang, C., Zhang, J., Han, F., Liu, D., Han, Y. No evidence for a causal link between Helicobacter pylori infection and irritable bowel syndrome: a Mendelian randomization study. Front Microbiol. 14, 1268492 (2024).","journal-title":"Front Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"100950","DOI":"10.1016\/j.neo.2023.100950","type":"journal-article","article-title":"Evidence based on Mendelian randomization: causal relationship between mitochondrial biological function and lung cancer and its subtypes","volume":"46","author":"Zhu","year":"2023","unstructured":"Zhu, K., Shi, J., Yang, R., Zhou, C., Liu, Z. Evidence based on Mendelian randomization: causal relationship between mitochondrial biological function and lung cancer and its subtypes. Neoplasia. 46, 100950 (2023).","journal-title":"Neoplasia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2101132","DOI":"10.1002\/adfm.202107678","type":"journal-article","article-title":"Charge-guided micro\/nano-hydrogel microsphere for penetrating cartilage matrix","volume":"31","author":"Lin","year":"2021","unstructured":"Lin, F., Wang, Z., Xiang, L., Deng, L., Cui, W. Charge-guided micro\/nano-hydrogel microsphere for penetrating cartilage matrix. Adv Funct Mater. 31, 2101132 (2021).","journal-title":"Adv Funct Mater"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3892\/ijo.2022.5406","type":"journal-article","article-title":"Long non-coding RNA 01614 hyperactivates WNT\/\u03b2-catenin signaling to promote pancreatic cancer progression by suppressing GSK-3\u03b2","volume":"61","author":"Chen","year":"2022","unstructured":"Chen, L.J. et al. Long non-coding RNA 01614 hyperactivates WNT\/\u03b2-catenin signaling to promote pancreatic cancer progression by suppressing GSK-3\u03b2. Int J Oncol. 61, 116 (2022).","journal-title":"Int J Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijbiomac.2022.07.098","type":"journal-article","article-title":"A cold-water polysaccharide-protein complex from Grifola frondosa exhibited antiproliferative activity via mitochondrial apoptotic and Fas\/FasL pathways in HepG2 cells","volume":"218","author":"Zhao","year":"2022","unstructured":"Zhao, J., Liang, K., Zhong, H., Liu, S., He, R., Sun, P. A cold-water polysaccharide-protein complex from Grifola frondosa exhibited antiproliferative activity via mitochondrial apoptotic and Fas\/FasL pathways in HepG2 cells. Int J Biol Macromol. 218, 1021-1032 (2022).","journal-title":"Int J Biol Macromol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e0010798","DOI":"10.1371\/journal.pntd.0010798","type":"journal-article","article-title":"IL-4, IL-10, CCL2 and TGF-\u03b2 as potential biomarkers for severity in Plasmodium vivax malaria","volume":"16","author":"Tovar Acero","year":"2022","unstructured":"Tovar Acero, C. et al. IL-4, IL-10, CCL2 and TGF-\u03b2 as potential biomarkers for severity in Plasmodium vivax malaria. PLoS Negl Trop Dis. 16, e0010798 (2022).","journal-title":"PLoS Negl Trop Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"103524","DOI":"10.1016\/j.ebiom.2021.103524","type":"journal-article","article-title":"Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis","volume":"70","author":"Strengert","year":"2021","unstructured":"Strengert, M. et al. Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis. EBioMedicine. 70, 103524 (2021).","journal-title":"EBioMedicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/jpm11040247","type":"journal-article","article-title":"Modulation of the dental pulp stem cell secretory profile by hypoxia induction using cobalt chloride","volume":"11","author":"Bhandi","year":"2021","unstructured":"Bhandi, S. et al. Modulation of the dental pulp stem cell secretory profile by hypoxia induction using cobalt chloride. J Pers Med. 11, 247 (2021).","journal-title":"J Pers Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jcpe.14080","type":"journal-article","article-title":"Alpha-ketoglutarate alleviates systemic lupus erythematosus-associated periodontitis in a novel murine model","volume":"52","author":"Mao","year":"2025","unstructured":"Mao, C. et al. Alpha-ketoglutarate alleviates systemic lupus erythematosus-associated periodontitis in a novel murine model. J Clin Periodontol. 52, 457-470 (2025).","journal-title":"J Clin Periodontol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/9783527684403.ch4","type":"journal-article","article-title":"Immunosuppressants: Remarkable Microbial Products","author":"Vaishnav","year":"2014","unstructured":"Vaishnav, P., Yoo, Y. J., Yoon, Y. J., Demain, A. L. Immunosuppressants: Remarkable Microbial Products. Bioactive Nat. Prod. Chem. Biol. 43-82 (2014).","journal-title":"Bioactive Nat. Prod. Chem. Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12967-025-06113-1","type":"journal-article","article-title":"Causal effect of three autoimmune diseases on brain functional networks and cerebrospinal fluid metabolites to underlie the pathogenesis of autoimmune psychosis: a two-sample Mendelian randomization analysis","volume":"23","author":"Shi","year":"2025","unstructured":"Shi, W.et al. Causal effect of three autoimmune diseases on brain functional networks and cerebrospinal fluid metabolites to underlie the pathogenesis of autoimmune psychosis: a two-sample Mendelian randomization analysis. J Transl Med. 23, 440 (2025).","journal-title":"J Transl Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"861724","DOI":"10.3389\/fcvm.2022.861724","type":"journal-article","article-title":"Baseline elevations of leukotriene metabolites and altered plasmalogens are prognostic biomarkers of plaque progression in systemic lupus erythematosus","volume":"9","author":"Baig","year":"2022","unstructured":"Baig, S., Vanarsa, K., Ding, H., Titus, A., McMahon, M., Mohan, C. Baseline elevations of leukotriene metabolites and altered plasmalogens are prognostic biomarkers of plaque progression in systemic lupus erythematosus. Front Cardiovasc Med. 9, 861724 (2022).","journal-title":"Front Cardiovasc Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","type":"journal-article","article-title":"Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases","volume":"24","author":"Warda","year":"2025","unstructured":"Warda, M. et al. Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases. Lipids Health Dis. 24, 147 (2025).","journal-title":"Lipids Health Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e23136","DOI":"10.1096\/fj.202300515R","type":"journal-article","article-title":"Cholesterol metabolism in T-cell aging: accomplices or victims","volume":"37","author":"Hu","year":"2023","unstructured":"Hu, C., Wu, H., Zhu, Q., Cao, N., Wang, H. Cholesterol metabolism in T-cell aging: accomplices or victims. FASEB J. 37, e23136 (2023).","journal-title":"FASEB J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","type":"journal-article","article-title":"Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases","volume":"33","author":"Song","year":"2021","unstructured":"Song, Y., Liu, J., Zhao, K., Gao, L., Zhao, J. Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases. Cell Metab. 33, 1911-1925 (2021).","journal-title":"Cell Metab"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00644.2005","type":"journal-article","article-title":"Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells","volume":"291","author":"Wei","year":"2006","unstructured":"Wei, Y., Wang, D., Topczewski, F., Demain, A. L. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol-Endocrinol Metab. 291 (2), E275-E281 (2006).","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/ijms18112313","type":"journal-article","article-title":"Effect of saturated stearic acid on MAP kinase and ER stress signaling pathways during apoptosis induction in human pancreatic \u03b2-cells is inhibited by unsaturated oleic acid","volume":"18","author":"R\u00e1mek","year":"2017","unstructured":"R\u00e1mek, J., N\u011bmcov\u00e1-F\u00fcrstov\u00e1, V., Pavl\u00edkov\u00e1, N., Kov\u00e1\u0159, J. Effect of saturated stearic acid on MAP kinase and ER stress signaling pathways during apoptosis induction in human pancreatic \u03b2-cells is inhibited by unsaturated oleic acid. Int J Mol Sci. 18(11), 2313 (2017).","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","type":"journal-article","article-title":"Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity","volume":"25","author":"Westerterp","year":"2017","unstructured":"Westerterp, M., et al. Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity. Cell Metab. 25 (6), 1294-1304.e6 (2017).","journal-title":"Cell Metab"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mco2.67","type":"journal-article","article-title":"UPLC-MS\/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients","volume":"2","author":"Chen","year":"2021","unstructured":"Chen, J., et al. UPLC-MS\/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients. MedComm. (2020). 2 (2), 269-278 (2021).","journal-title":"MedComm (2020)"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/rheumatology\/keaa225","type":"journal-article","article-title":"Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus","volume":"59","author":"L\u00f3pez","year":"2020","unstructured":"L\u00f3pez, P., et al. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus. Rheumatology (Oxford). 59 (7), 1795 (2020).","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69038\/cholesterol-stearamide-mediate-lymphocyte-apoptosis-cytokine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:55Z","timestamp":1792592455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69038\/cholesterol-stearamide-mediate-lymphocyte-apoptosis-cytokine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":43,"journal-issue":{"issue":"224","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/69038","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}